Bioengineers are creating human body parts to replace organs and manage life-threatening diseases. How techniques like 3-D printing and stem cell research are driving medical advances and raising ethical questions
The Justice Department signals a new stance on medical marijuana. The U.S. attorney general directs federal prosecutors not to pursue medical marijuana cases in states where it’s legal. What the policy shift may mean for patients and the federal war on drugs.
- Gil Kerlikowske director, the White House Office of National Drug Control Policy.
- Carrie Johnson reporter, The Washington Post.
- Ethan Nadelmann executive director, the Drug Policy Alliance.
- Tom Riley former associate director of the Office of National Drug Control Policy (2001-2009).
Most Recent Shows
Cuba releases American contractor Alan Gross after five years' imprisonment on espionage charges. The U.S. releases several Cubans in exchange. Details on the prisoner swap and the future of U.S.-Cuban relations.
The ebola epidemic in West Africa is not just a health care crisis. It has affected every corner of society in the countries most affected. Schools have been closed for months, infrastructure projects have been put on hold and GDP growth has slowed to a crawl. A discussion of the social and economic cost of Ebola in Guinea, Liberia and Sierra Leone.
Russia’s ruble strengthened today but it remains volatile after losing about 20 percent of its value yesterday. Diane and her guests discuss what falling oil prices and new U.S. sanctions mean for the Kremlin and the Russian economy.